Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 25,300 shares at $161.28 ($4.0M) on 2021-08-12, disclosed to the SEC on 2021-08-16.
Open-market sale of $4.0M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.19 | 2,100 | $330K | 8.2% |
| 2 | $158.07 | 2,400 | $379K | 9.4% |
| 3 | $159.13 | 3,213 | $511K | 12.6% |
| 4 | $159.13 | 3,213 | $511K | 12.6% |
| 5 | $160.00 | 3,400 | $544K | 13.4% |
| 6 | $161.28 | 5,087 |
| $820K |
| 20.3% |
| 7 | $161.28 | 5,087 | $820K | 20.3% |
| 8 | $161.84 | 800 | $129K | 3.2% |
| Total | $159.94 avg | 25,300 | $4.0M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |